Dr. Ari Baron has contributed to 3 publications.
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
Treon, S.P., Soumerai, J.D., Branagan, A.R., Hunter, Z.R., Patterson, C.J., Ioakimidis, L., Chu, L., Musto, P., Baron, A.D., Nunnink, J.C., Kash, J.J., Terjanian, T.O....; Clin Cancer Res. 2009-01-01.
See more >>
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
Burstein, H.J., Keshaviah, A., Baron, A.D., Hart, R.D., Lambert-Falls, R., Marcom, P.K., Gelman, R., Winer, E.P.; Cancer. 2007 Sep 1.
See more >>
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.
Ross, H. J., Hart, L. L., Swanson, P. M., Rarick, M. U., Figlin, R. A., Jacobs, A. D., McCune, D. E., Rosenberg, A. H., Baron, A. D., Grove, L. E., Thorn, M. D., Mille...; Lung Cancer. 2006 Oct.
See more >>